Recurrent Urinary Tract Infection Clinical Trial
Official title:
Addressing Preference as a Patient-centered Outcome to Prevent Recurrent Urinary Tract Infection (rUTI) in Post-menopausal Women: a Cross-over Randomized Controlled Trial
Vaginally applied estrogen has been shown to decrease the incidence of Recurrent Urinary Tract Infection (rUTI) in post-menopausal women. However, prior studies have shown the compliance rate for topical estrogen cream is low. The vaginal estradiol tablet has been shown to be preferred by patients being treated for genitourinary syndrome of menopause and has improved compliance. There are no studies looking at the preference of post-menopausal women with rUTI for vaginal estradiol tablet as an alternative to vaginal estradiol cream.
This study is a cross-over randomized study to assess preference. Participants will be in the study for 6 months, they will use vaginal estradiol cream for 3 months and vaginal estradiol tablet for 3 months. Patients who meet diagnostic criteria for rUTI will be recruited. Group A participants will start with 3 months of cream and then switch to tablets. Group B will start with 3 months of tablets and switch to cream. In addition, participants may be started on other supplemental medications (Cranberry, D-mannose, methenamine) at the discretion of their provider. Patients will get monthly phone calls to assess for side effects, safety concerns, and symptoms of UTI. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02357758 -
Effects of Antibiotic Prophylaxis on Recurrent UTI in Children
|
Phase 4 | |
| Completed |
NCT04306731 -
Effect of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections.
|
N/A | |
| Recruiting |
NCT05553652 -
The Effect of ASTARTE™ on Recurrent Urinary Tract Infection
|
N/A | |
| Completed |
NCT01958073 -
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
|
Phase 4 | |
| Recruiting |
NCT05652374 -
Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study
|
Phase 4 | |
| Recruiting |
NCT06124820 -
RCT Comparing Intravaginal Laser Therapy to Sham in Post-menopausal Women With Recurrent Urinary Tract Infections
|
N/A | |
| Recruiting |
NCT04807894 -
Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
|
Phase 4 | |
| Enrolling by invitation |
NCT04077580 -
The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing in Elderly Women With Recurrent UTI
|
Phase 4 | |
| Terminated |
NCT03143920 -
Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder
|
Early Phase 1 | |
| Recruiting |
NCT04859621 -
Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections
|
Phase 2 | |
| Terminated |
NCT04831840 -
Recurrent Urinary Tract Infections and the Microbiome
|
||
| Withdrawn |
NCT03854396 -
Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women
|
Phase 3 | |
| Completed |
NCT02705495 -
Acupuncture for Prevention of Recurrent Urinary Tract Infections.
|
N/A | |
| Active, not recruiting |
NCT05537519 -
Phage Therapy for the Treatment of Urinary Tract Infection
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06035601 -
EHR-integrated rUTI Texting Platform
|
N/A | |
| Not yet recruiting |
NCT04285320 -
Antibiotic Bladder Instillations vs. Oral Suppression for the Treatment of Recurrent Urinary Tract Infections
|
Phase 4 | |
| Recruiting |
NCT03142295 -
Controlled Human Urine Transfusion for UTI
|
N/A | |
| Recruiting |
NCT05895578 -
Effect of a Probiotic on the Urinary Tract Microbiota of Participants With Recurrent Urinary Tract Infection.
|
N/A | |
| Completed |
NCT00214045 -
Rigid Versus Flexible Cystoscopy in Women
|
N/A | |
| Enrolling by invitation |
NCT05551949 -
Preventing Recurrent UTI With Vaginal Estrogen
|
Phase 4 |